¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"gene defect"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • septation defect
    »çÀ̸·Çü¼º°á¼Õ, Áß°ÝÇü¼º°á¼Õ
  • skull bone defect
    ¸Ó¸®»À°á¼Õ, µÎ°³°ñ°á¼Õ
  • ventricular septal defect
    ½É½Ç»çÀ̸·°á¼Õ, ½É½ÇÁ߰ݰá¼Õ
  • visual defect
    ½Ã(°¢)°á¼Õ
  • visual field defect
    ½Ã¾ß°á¼Õ
  • window defect
    â¹®ºñħ, â¹®Çü±¤
  • autosomal gene
    º¸Åë¿°»öüÀ¯ÀüÀÚ
  • additive gene
    »ó°¡À¯ÀüÀÚ
  • allelic gene
    ´ë¸³À¯ÀüÀÚ
  • complementary gene
    º¸Á·À¯ÀüÀÚ, »óÈ£º¸ÃæÀ¯ÀüÀÚ
  • control gene
    Á¦¾îÀ¯ÀüÀÚ
  • cooperating gene
    Çùµ¿À¯ÀüÀÚ
  • catabolite (gene) activator protein
    ºÐÇØ´ë»ç»ê¹°(À¯ÀüÀÚ)Ȱ¼º´Ü¹éÁú
  • calcitonin gene-related peptide
    Ä®½ÃÅä´ÑÀ¯ÀüÀÚ°ü·ÃÆéƼµå
  • candidate gene
    Èĺ¸À¯ÀüÀÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • regulator gene
    Á¶ÀýÀ¯ÀüÀÚ
  • reporter gene
    Á¤º¸Á¦°øÀ¯ÀüÀÚ
  • repressor gene
    ¾ïÁ¦À¯ÀüÀÚ
  • retinoblastoma gene
    ¸Á¸·¸ð¼¼Æ÷Á¾À¯ÀüÀÚ
  • structural gene
    ±¸Á¶À¯ÀüÀÚ
  • suicide gene
    ÀÚ»ìÀ¯ÀüÀÚ
  • supressor gene
    ¾ïÁ¦À¯ÀüÀÚ
  • tumor suppressor gene
    Á¾¾ç¾ïÁ¦À¯ÀüÀÚ
  • single major gene locus model
    ´ÜÀÏÁÖ¿äÀ¯ÀüÀÚÀÚ¸®¸ðÇü
  • abdominal wall defect
    ¹èº®°á¼Õ
  • aggregation defect
    ÀÀÁý°áÇÔ
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • associated defect
    ¿¬ÇÕ°áÇÔ, ¿¬ÇÕ°á¼Õ, ¼ö¹ÝÀå¾Ö
  • atrial septal defect
    ½É¹æ»çÀ̸·°á¼Õ, ½É¹æÁ߰ݰá¼Õ
  • atrioventricular canal defect
    ¹æ½Ç°ü°á¼Õ(Áõ)
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Gene therapy
    À¯ÀüÀÚÄ¡·á(ö½Öû)
  • Hfr mediated gene transfer
    °íºóµµÀçÁ¶ÇÕ¼¼Æ÷¸Å°³ À¯ÀüÀÚÀüÀÌ
  • Onc gene
    Onc À¯ÀüÀÚ
  • Src gene
    Src À¯Àü(ÀÎ)ÀÚ
  • T cell receptor gene
    T¼¼Æ÷[Ç׿ø]¼ö¿ëü À¯ÀüÀÚ
  • additive gene
    »ó°¡À¯ÀüÀÚ(ßÓÊ¥ë¶îîí­).
  • aniridia,pax-6 gene
    PAX-6 À¯ÀüÀÚ(¡­ë¶îîí­)
  • apc gene
    APC À¯ÀüÀÚ(¡­ë¶îîí­)
  • gene
    À¯ÀüÀÚ(ë¶îîí­)
  • gene
    À¯ÀüÀÚ
  • gene amplification
    À¯ÀüÀÚÁõÆø
  • gene amplification
    À¯ÀüÀÚ ÁõÆø
  • gene analyses
    À¯ÀüÀںм®
  • gene analysis
    À¯ÀüÀںм®(¡­ÝÂà°).
  • gene analysis
    À¯ÀüÀںм®.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • gene frequency
    À¯ÀüÀÚºóµµ
  • gene genetics
    À¯ÀüÀÚÀ¯ÀüÇÐ(¡­ë¶îîùÊ).
  • gene imbalance
    À¯ÀüÀÚºÒÆòÇü(ÝÕøÁû¬).
  • gene imbalance
    À¯ÀüÀÚºÒÆòÇü.
  • gene map
    À¯ÀüÀÚÁöµµ
  • gene map order
    À¯ÀüÀÚÁöµµ¼ø¼­
  • gene mutation
    ÇØºÎ
  • gene mutation
    À¯ÀüÀÚµ¹¿¬º¯ÀÌ(ÔÍæÔܨì¶).
  • gene mutation
    À¯ÀüÀÚµ¹¿¬º¯ÀÌ.
  • gene mutation
    À¯ÀüÀÚµ¹¿¬º¯ÀÌ.
  • gene mutation
    À¯ÀüÀÚ(µ¹¿¬)º¯ÀÌ
  • gene recombination
    À¯ÀüÀÚÀçÁ¶ÇÕ(î¢ðÚùê).
  • gene recombination
    À¯ÀüÀÚÀçÁ¶ÇÕ.
  • gene recombination
    À¯ÀüÀÚÀçÁ¶ÇÕ
  • gene recombination
    À¯ÀüÀÚÀçÁ¶ÇÕ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Chromosomal defect
    ¿°»öü°áÇÔ
    [¿¾ ¿ë¾î] ¿°»öü°áÇÔ
  • Heritable defect
    À¯Àü°áÇÔ
    [¿¾ ¿ë¾î] À¯Àü¼º°áÇÔ
  • Fusion defect
    À¶ÇÕ°áÇÔ
    [¿¾ ¿ë¾î] À¶ÇÕ°áÇÔ
  • Fusion defect (Cleft palate)
    À¶ÇÕ°áÇÔ (ÀÔõÀå°¥¸²Áõ)
    [¿¾ ¿ë¾î] À¶ÇÕ°áÇÔ (ÀÔõÀå°¥¸²Áõ)
  • Aggregation defect
    ÀÀÁý°áÇÔ
    [¿¾ ¿ë¾î] ÀÀÁý¼º°áÇÔ
  • Migration defect
    ÀÌÁÖ°áÇÔ
    [¿¾ ¿ë¾î] ÀÌÁÖ°áÇÔ
  • Defect of palate
    ÀÔõÀå°áÇÔ
    [¿¾ ¿ë¾î] ±¸°³°áÇÔ
  • Total heart defect
    Àüü½ÉÀå°áÇÔ
    [¿¾ ¿ë¾î] ½ÉÀåÀü°áÇÔ
  • Plication defect
    ÁÖ¸§Çü¼º°áÇÔ
    [¿¾ ¿ë¾î] ÁÖ¸§Çü¼º°áÇÔ
  • Plication defect (Schistomyelia)
    ÁÖ¸§Çü¼º°áÇÔ (ô¼ö°¥¸²Áõ)
    [¿¾ ¿ë¾î] ÁÖ¸§Çü¼º°áÇÔ (ô¼ö°¥¸²Áõ)
  • Defect of implantation
    Âø»ó°áÇÔ
    [¿¾ ¿ë¾î] Âø»ó°áÇÔ
  • Defect of spinal cord
    ô¼ö°áÇÔ
    [¿¾ ¿ë¾î] ô¼ö°áÇÔ
  • Defect of vertebral column
    ôÁÖ°áÇÔ
    [¿¾ ¿ë¾î] ôÁÖ°áÇÔ
  • Perforation defect (Imperforate anus)
    õ°ø°áÇÔ (Ç×¹®¸·ÈûÁõ)
    [¿¾ ¿ë¾î] õ°ø°áÇÔ (Ç×¹®¸·ÈûÁõ)
  • Prenatal defect
    Ãâ»ýÀÌÀü°áÇÔ
    [¿¾ ¿ë¾î] Ãâ»ýÀü°áÇÔ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • gene transfection
    À¯ÀüÀÚ ÀÌÀÔ(ë¶îîíºì¹ìý)
  • gene walking
    À¯ÀüÀÚ(ë¶îîí­) °È±â
  • hemizygous gene
    ¹ÝÁ¢ÇÕ À¯ÀüÀÚ(ÚâïÈùêë¶îîí­)
  • hgh-mutability gene
    °íº¯ÀÌ´É À¯ÀüÀÚ(ÍÔܨì¶Òöë¶îîí­)
  • histocompatibility gene
    Á¶Á÷ ÀûÇÕ¼º À¯ÀüÀÚ(ðÚòÄîêùêàõë¶îîí­)
  • holandric gene
    ¿õ¼º À¯ÀüÀÚ(ê©àõë¶îîí­)
  • hybrid gene
    Æ¢±âÀ¯ÀüÀÚ(ë¶îîí­)
  • immune response gene
    ¸é¿ª ´ëÀÀ À¯ÀüÀÚ(Øóæ¹Óßëëë¶îîí­)
  • immunoglobulin gene
    ¸é¿ª(Øóæ¹)±Û·ÎºÒ¸° À¯ÀüÀÚ(ë¶îîí­)
  • indispensable gene
    ºÒ°¡°á À¯ÀüÀÚ(ÝÕʦÌÀë¶îîí­)
  • integrating gene
    ÅëÇÕ À¯ÀüÀÚ(÷Öùêë¶îîí­)
  • interrupted gene
    ´Ü¼Ó À¯ÀüÀÚ(Ó¨áÙë¶îîí­)
  • Ir gene
    Ir À¯ÀüÀÚ
  • jumping gene
    ¶Ù±â À¯ÀüÀÚ(ë¶îîí­)
  • late gene
    ¸¸±âÀ¯ÀüÀÚ(عѢë¶îîí­)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CRYG gamma crystallin gene
din damage inducible [gene]
DMGT deoxyribonucleic acid-mediated gene transfer
FHIT fragile histidine triad [gene]
GAG glycosaminoglycan; group-specific antigen gene
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
alpha-CGRP Alpha calcitonin gene-related peptide
APO E Apolipoprotein E gene
CGRP CT gene-related peptide
CGRP-LI Calcitonin gene related peptide-like immunoreactivity
CGRP-IR Calcitonin gene-related peptide immunoreactive
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • paraplacental chorionic defect
    ÅÂ¹Ý °ç À¶¸ð¸· °áÇÔ
  • perceptual defect
    Áö°¢ °á¼Õ
  • peroxidase defect
    °ú»êÈ­È¿¼Ò °á¼Õ
  • punch out defect
    ±¸¸Û °á¼Õ
  • qualitative platelet defect
    Á¤»ó Ç÷¼ÒÆÇ °áÇÌÁõ, ÁúÀû Ç÷¼ÒÆÇ °áÇÔ
  • quantum defect
    ¾çÀÚ °á¼Õ
  • skeletal defect
    °ñ°Ý °á¼Õ
  • small atrial septal defect
    ¹Ì¼¼ ½É¹æ Áß°Ý °á¼Õ
  • substance defect
    ¹°Áú °áÇÌ
  • superficial defect
    Ç¥À缺 °á¼Õ
  • ventricular septal defect
    ½É½Ç Áß°Ý °á¼Õ
    ¼±Ãµ¼º ½ÉÁúȯ¿¡¼­ ºóµµ°¡ ³ôÀº °ÍÀÇ ÇϳªÀÌ´Ù. ½É½Ç Áß°Ý¿¡ °á¼ÕÀÌ ÀÖ´Â °ÍÀ» ¸»ÇÑ´Ù. º¸Åë ½É½Ç Áß°Ý ¸·¼º ºÎÀ§ÀÇ °á¼ÕÀε¥ ±Ù¼º ºÎÀ§¿¡ °á¼ÕÀÌ ÀÖ´Â °Íµµ ÀÖ´Ù. °á¼Õ°øÀÇ Å©±â´Â ´Ù¾çÇÏ´Ù. ÀϹÝÀûÀ¸·Î ¿¹ÈÄ´Â ¾çÈ£Çϰí ÀÚ¿¬ Æó¼âµµ ÀÖ´Ù. Ä¡·á´Â ¿Ü°úÀûÀ¸·Î Æó¼â¸¦ ÇÑ´Ù.
  • visual field defect
    ½Ã¾ß °á¼Õ
    ¸Á¸·¿¡¼­ ´ë³ú ÇÇÁú¿¡ À̸£´Â ½Ã°¢°èÀÇ Àå¾Ö·Î ÀÎÇÑ ½Ã¾ßÀÇ ÀÌ»ó.
  • wedge shape defect
    ¼³»ó °á¼Õ
  • window defect
    â¹® ºñħ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
rab gene 1. <molecular biology> One of the three main groups of ras like genes specifying small GTP-binding proteins (the others are ras and rho). Rab proteins are involved in vesicular traffic and seem to control translocation from donor to acceptor membranes.
2. <cell biology> Gene family in plants responsive to abscisic acid: encode proteins of 15-17 kD.
(18 Nov 1997)
pair rule gene <molecular biology> A segmentation gene, expressed sequentially between gap genes and segment polarity genes. In development of Drosophila, a set of about 8 genes that are expressed only in alternate segments (odd or even) of the developing embryo. Loss of function mutants thus lack alternate segments.
Examples: even skipped (eve), fushi tarazu (ftz), hairy.
(18 Nov 1997)
variable gene <molecular biology> Those regions in the amino acid sequence of both the heavy and the light chains of immunoglobulins where there is considerable sequence variability from one immunoglobulin to other of the same class, in contrast to constant sequence (C) regions. The V regions are associated with the antigen binding areas. They contain hypervariable regions of particularly high sequence diversity.
(18 Nov 1997)
gap gene <molecular biology> Segmentation genes involved in specifying relatively coarse subdivisions of the embryo.
They are expressed sequentially in development between egg polarity genes and pair rule genes. In Drosophila, there are at least three such genes, for example Kruppel.
(18 Nov 1997)
gene <cell biology, molecular biology> Originally defined as the physical unit of heredity, it is probably best defined as the unit of inheritance that occupies a specific locus on a chromosome, the existence of which can be confirmed by the occurrence of different allelic forms.
Genes are formed from DNA, carried on the chromosomes and are responsible for the inherited characteristics that distinguish one individual from another. Each human individual has an estimated 100,000 separate genes.
Given the occurrence of split genes, it might be redefined as the set of DNA sequences (exons) that are required to produce a single polypeptide.
(09 Oct 1997)
gene activation The process of activation of a gene so that it is expressed at a particular time. This process is crucial in growth and development.
(05 Mar 2000)
gene amplification <molecular biology> Selective replication of DNA sequence within a cell, producing multiple extra copies of that sequence. The best known example occurs during the maturation of the oocyte of Xenopus, where the set (normally 500 copies) of ribosomal RNA genes is replicated some 4,000 times to give about 2 million copies.
(18 Nov 1997)
gene bank A group of genes which are coordinately controlled.
(09 Oct 1997)
gene cloning <molecular biology> The insertion of a DNA sequence into a vector that can then be propagated in a host organism, generating a large number of copies of the sequence.
(18 Nov 1997)
gene cluster A set of closely related genes that code for the same or similar proteins and which are usuallygrouped together on the same chromosome.
(09 Oct 1997)
gene conversion <molecular biology> A phenomenon in which alleles are segregated in a 3:1 not 2:2 ratio in meiosis. May be a result of DNA polymerase switching templates and copying from the other homologous sequence or a result of mismatch repair (nucleotides being removed from one strand and replaced by repair synthesis using the other strand as template).
(18 Nov 1997)
gene deletion The total loss (or absence) of a gene. Gene deletion plays a role in birth defects and in the development of cancer.
(12 Dec 1998)
gene disorder Hereditary disorder caused by a mutant allele of a single gene (e.g., Duchenne muscular dystrophy, retinoblastoma, sickle cell disease).
Compare polygenic disorders.
(05 Mar 2000)
gene disruption Use of both in vitro and in vivo recombination to substitute an easily selected mutant gene for a wild-type gene.
(09 Oct 1997)
gene divergence The difference (expressed as a percentage) in the nucleotide sequencesbetween two related genes that developed from the same ancestral gene.
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á